A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT05121480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Cohort Study Investigating the Effect of EDP1815 in Participants for the Treatment of Mild, Moderate and Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to determine whether the study drug, EDP1815, is safe and effective in the treatment of atopic dermatitis compared with placebo. The study will look at different doses of the study drug, and whether there are differences when the drug is given once daily or twice daily.
Study identification
- NCT ID
- NCT05121480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 421 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2022 (Actual)
- Primary completion
- Mar 9, 2023 (Actual)
- Completion
- Mar 28, 2023 (Actual)
- Last update posted
- Aug 16, 2023
2022 – 2023
United States locations
- U.S. sites
- 27
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USA-131 | Birmingham | Alabama | 35244 | — |
| USA-112 | Fountain Valley | California | 92708 | — |
| USA-123 | Fremont | California | 94538 | — |
| USA-114 | Newport Beach | California | 92660 | — |
| USA-101 | Fort Lauderdale | Florida | 33308 | — |
| USA-124 | Jacksonville | Florida | 32216 | — |
| USA-108 | Miami | Florida | 33165 | — |
| USA-120 | Miami | Florida | 33175 | — |
| USA-105 | Miramar | Florida | 33027 | — |
| USA-102 | Orlando | Florida | 32801 | — |
| USA-115 | Sweetwater | Florida | 33172 | — |
| USA-126 | Tampa | Florida | 33613 | — |
| USA-106 | Tampa | Florida | 33624 | — |
| USA-118 | Sandy Springs | Georgia | 30328 | — |
| USA-111 | Clarksville | Indiana | 47129 | — |
| USA-116 | Louisville | Kentucky | 40241 | — |
| USA-119 | Baton Rouge | Louisiana | 70806 | — |
| USA-109 | Metairie | Louisiana | 70006 | — |
| USA-125 | Silver Spring | Maryland | 20902 | — |
| USA-130 | Ann Arbor | Michigan | 48103 | — |
| USA-121 | Columbus | Ohio | 43221 | — |
| USA-128 | Concord | Ohio | 44077 | — |
| USA-104 | Portland | Oregon | 97239 | — |
| USA-127 | Memphis | Tennessee | 38119 | — |
| USA-117 | Frisco | Texas | 75034 | — |
| USA-110 | Pflugerville | Texas | 78660 | — |
| USA-113 | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05121480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05121480 live on ClinicalTrials.gov.